Please login to the form below
New Accounts: June - PR and medical education
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period March 2006 to May 2006 inclusive
The following tables list new pharmaceutical account wins notified to us by the winning
agencies for the period March 2006 to May 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
|
|
|
|
|
|
The Alliance for Better Bone (P&G; S-A) |
Actonel |
Osteoporosis |
Ketchum |
|
ABPI |
The Involved Patient Initiative |
N/A |
Shire Health London |
|
Altana Pharma |
Pantoprazole |
Gastrointestinal |
Shire Health London |
|
Apitope Technology |
Phase Ib/IIa therapeutic biological vaccine |
MS |
Healthcare Solutions |
|
AstraZeneca |
Crestor |
Cardiovascular |
Zaicom MMC |
|
GlaxoSmithKline |
HPV vaccine |
Gynaecology/oncology |
Succinct Communications |
|
GlaxoSmithKline |
Telzir |
HIV |
90TEN Healthcare |
|
GrÈnenthal International |
Transtec - publications planning |
Pain |
Zaicom MMC |
|
Kimberly-Clark |
InteguSeal |
Antimicrobial surgical skin preparation |
De Facto Medica |
|
Link Pharmaceuticals |
Gliadel implant |
Oncology |
Spink Consumer Relations |
|
Merck SantÈ |
Glucovance |
Type II diabetes |
De Facto Medica |
|
NICE |
At Ri-SK? awareness campaign |
Solar keratosis |
hsdcommunications |
|
NICE |
Quick Reference Guides |
N/A |
90TEN Healthcare |
|
Pfizer |
Oncology portfolio |
Managed entry |
Succinct Communications |
|
Plethora/Timm |
Osbon ErecAid |
Male sexual dysfunction |
De Facto Medica |
|
ProStrakan |
Rapinyl |
Breakthrough pain |
Litmus/CCA |
|
Recordati |
Zanidip |
Cardiology |
LeapFrog Medical Communications |
|
Roche Pharmaceuticals |
Fuzeon/Invirase |
HIV |
Aurora |
|
Schering-Plough |
Nasonex |
Respiratory disease |
LeapFrog Medical Communications |
|
Servier |
Various |
Cardiology |
Zaicom MMC |
|
Speedel |
SPP301 |
Hypertension |
De Facto Medica |
|
UCB |
Professional development programme |
ADHD |
Huntsworth Health Avenue |
|
Wyeth Consumer Health |
Anadin |
Analgesics |
Spink Consumer Relations |
Share
Related Hub content
Featured jobs
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Scientific Director
-
Highly Competitive Salary &Benefits
- Experienced Editor, London, Medical Communications
-
Competitive package
-
Account Director
-
Negotiable
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Scientific Team Lead
-
Competitive Salary
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
- Account Manager, Healthcare Advertising
-
Salary TBC
-
Associate Medical Director
-
Salary TBC
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Director Healthcare PR Communications
-
Salary TBC
-
Associate Medical Director
-
Highly Competitive
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Director – Global Healthcare PR
-
Salary TBC
Subscribe to our email news alerts
- Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
- Novartis claims a rare win at ESMO for PI3K inhibitor class
- Merck’s Bavencio joins first-line kidney cancer face-off
- How pharma should navigate Artificial Intelligence (AI)
- Encouraging data for GenSight’s blinding retinal disease gene therapy
- Lonely planet: why there is dwindling value in pharma travelling alone
PMHub
Streaming Well
Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....
Latest intelligence
- Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
- Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Quick links
Infographics
